Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

Joseph D. Tobias

Status: Completed

Conditions: Traumatic Brain Injury

Treatments: Drug: Remifentanil

Study type: Observational

Funder types: Other

Identifiers

NCT02049320

IRB13-00478

Details and patient eligibility

About

This is a descriptive retrospective study designed to measure the efficacy of remifentanil sedation and the ability to perform frequent neurological examinations of patients with traumatic brain injuries.

Enrollment: 38 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients previously admitted to the hospital presenting with traumatic brain injury (TBI)
• Patients who have undergone sedation after presenting with TBI

Exclusion criteria

• None

Trial design

38 participants in 1 patient group

Remifentanil

Description:

Patients sedated using Remifentanil

Treatment:

Drug: Remifentanil